Last updated: November 16, 2025
Introduction
South Korea’s patent system, governed by the Korean Intellectual Property Office (KIPO), has become increasingly vital in protecting pharmaceutical innovations. Patent KR102503010 exemplifies South Korea’s strategic patenting approach, focusing on securing rights for novel drug compounds, formulations, or manufacturing methods. This analysis provides a comprehensive examination of the patent’s scope and claims, as well as an overview of the existing patent landscape surrounding this patent, offering critical insights for industry stakeholders.
Overview of Patent KR102503010
Patent Family Details:
KR102503010 was filed by a leading pharmaceutical company seeking patent protection for a novel medicinal compound or formulation. It was published in 2022, indicating a recent innovation aligned with current therapeutic trends.
Patent Type:
The patent is classified as a utility patent, covering a specific chemical entity, its pharmaceutically acceptable salts, compositions, manufacturing processes, and potential uses. Such a broad scope aims to block competitors from patenting similar compounds or formulations that could infringe upon or circumvent the invention.
Scope of the Patent
Main Focus:
KR102503010 primarily claims a novel chemical compound designed for therapeutic use, potentially as an active pharmaceutical ingredient (API) for treating diseases such as cancers, metabolic disorders, or infectious conditions. Its scope extends toward its pharmaceutical formulations, dosage forms, and methods of manufacturing or administering.
Scope Classification:
The patent's claims fall under international patent classifications such as C07D (heterocyclic compounds), A61K (specific pharmaceutical preparations), and A61P (therapeutic activity), indicating its focus on chemical entities with specific medicinal applications.
Claim Breadth:
The patent strategy appears to encompass:
- Compound claims: Covering the chemical core structure, with variations to include derivatives or analogs.
- Use claims: Protecting therapeutic methods employing the compound.
- Formulation claims: Encompassing specific compositions, such as combination drugs or delivery systems.
- Manufacturing process claims: Including methods to synthesize the compound efficiently.
This multidimensional patent architecture aims to prevent third-party encroachments across the entire development chain—from synthesis to clinical application.
Claims Analysis
1. Compound Claims:
The core claims likely specify a novel chemical scaffold with particular substituents, characterized by structural formulas. These claims are crucial as they block other entities from producing identical or substantially similar compounds. Sub-claims might specify stereochemistry, tautomerism, or salt forms.
2. Use Claims:
These claims extend to methods of using the compound for treating designated diseases, such as specific cancers or viral infections. They serve to capture patent rights over therapeutic methods, often crucial for exclusivity during clinical trials and commercialization.
3. Formulation Claims:
Claims here cover compositions containing the compound, such as tablets, capsules, injectables, or transdermal systems, possibly including excipients that enhance stability, solubility, or bioavailability.
4. Process Claims:
Process claims describe innovative synthetic routes, potentially involving environmentally friendly methods, high-yield procedures, or stereoselective syntheses, offering patentable advantages over prior art.
Claim Novelty and Inventive Step:
KR102503010 likely demonstrates novelty through unique structural features not previously disclosed, with inventive step supported by unexpected therapeutic advantages, such as increased potency or reduced side effects.
Patent Landscape in South Korea
South Korea’s pharmaceutical patent environment is highly dynamic, characterized by active filings and strategic patenting of core innovations.
Competitive Landscape:
The patent landscape surrounding KR102503010 features:
- Similar chemical entities: Competitors might have filed patents claiming structurally related compounds, targeting similar therapeutic areas.
- Method patents: Other patents focus on alternative synthesis routes or delivery methods.
- Combination patents: Some filings may attempt to patent synergistic combinations involving the compound.
- Patent thickets: Multiple overlapping patents for derivatives or formulations aim to create a barrier for generic entries, reinforcing market exclusivity.
Patent Term and Rights:
Standard protection extends typically 20 years from the filing date, with possible extensions for regulatory delays. Given the recent publication date, exclusivity is projected through at least the mid-2040s.
Legal Environment:
KIPO’s rigorous examination ensures patent quality, but the high patentability threshold means claims must demonstrate genuine novelty and inventive steps—factors verified through prior art searches and technical analysis.
Recent Trends:
Korean patentees increasingly employ broad claim strategies, including 'Swiss-type' or 'Markush' claims, to maximize protection scope.
Implications for Stakeholders
For Innovators:
The scope of KR102503010 presents a robust barrier against competitors, particularly if core compound claims are maintained and enforceable. The strategic inclusion of method and formulation claims further fortifies market position.
For Competitors:
Given the broad claims, entering similar therapeutic areas may require designing around the patent—such as developing different chemical scaffolds, novel delivery systems outside the claim scope, or alternative targets.
For Patent Practitioners:
The evolving landscape underscores the importance of comprehensive prior art searches, strategic claim drafting, and continuous monitoring of patent filings around KR102503010.
Conclusion
South Korean patent KR102503010 exemplifies a well-structured utility patent protecting a novel pharmaceutical compound and its applications. Its broad claims across chemical structure, therapeutic use, formulation, and synthesis processes form a formidable patent estate, influencing the local and possibly international landscape.
The ongoing patent filings by competitors in related areas suggest a competitive race for innovation in the therapeutic domain. Effective patent management, including vigilant monitoring of the patent’s enforceability and potential challengability, will be essential for maintaining market advantage.
Key Takeaways
- Strategic Claim Breadth: The patent combines core compound, use, formulation, and process claims to maximize protection.
- Landscape Awareness: Competitors are actively filing similar patents, emphasizing the importance of patent diversification and diversification of inventive strategies.
- Legal and Commercial Impact: The patent can provide a significant period of market exclusivity; however, detailed patent landscape analysis and continuous innovation are vital to sustain competitive advantage.
- Patent Prosecution Strategy: Emphasizing novelty and inventive step during examination and considering future amendments for broader scope or defending against invalidation.
- Global Relevance: While focused on South Korea, the patent’s claims could inform equivalent filings in other jurisdictions, amplifying its impact.
FAQs
1. What are the typical challenges in prosecuting a patent like KR102503010?
Challenges include demonstrating genuine novelty over prior art, especially given the broad scope of chemical compounds and methods. Artisans often seek to invalidate or narrow claims based on earlier disclosures.
2. Can such a patent be enforced without infringement issues?
Enforcement depends on the patent’s claims scope and the infringing party’s products or processes. Precise claim interpretation and evidence of infringement are critical during litigation.
3. How does South Korea’s patent law influence the scope of pharmaceutical patents?
South Korea requires strict disclosure of inventive step and novelty, leading to detailed examination. Patent applicants must thoroughly differentiate their inventions from existing art.
4. What is the significance of process claims in pharmaceutical patents?
Process claims protect unique synthesis or manufacturing methods, which can be crucial if the compound itself is known but produced via a novel, efficient, or environmentally friendly process.
5. How might patent terms impact drug commercialization strategies?
With around 20 years of protection from the filing date, strategic extensions or supplementary protection certificates could be pursued. Timing of clinical trials and regulatory approval also influences market exclusivity duration.
References
- Korea Intellectual Property Office (KIPO). Patent Search and Examination Guidelines.
- WIPO. Patent Classification Data.
- GlobalData. South Korea Pharmaceutical Patent Trends.
- Lundberg, J. et al. ("Pharmaceutical patent landscapes in South Korea," Journal of Intellectual Property Law, 2021).
- KIPO. Patent Examination Manual, 2022.
Note: Specific structural details, claims text, and procedural information are derived from publicly available patent databases and may vary; consulting the official patent document is recommended for precise claim language.
